
Sign up to save your podcasts
Or
Drs. Gurbakhash Kaur and Danai Dima discuss next-gen CAR T and bispecific therapies for myeloma, including agents for extramedullary disease and GPRC5D targets.
4.8
2626 ratings
Drs. Gurbakhash Kaur and Danai Dima discuss next-gen CAR T and bispecific therapies for myeloma, including agents for extramedullary disease and GPRC5D targets.
131 Listeners
86,750 Listeners
111,917 Listeners
15,335 Listeners
29 Listeners